QT
ACIU icon

Quantamental Technologies’s AC Immune ACIU Stock Holding History

Quantamental Technologies’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,743
Closed -$9K – 422
2019
Q3 		$9K Sell
1,743
-320
-16% -$1.72K ﹤0.01% 1327
2019
Q2 		$11K Buy
+2,063
New +$10.5K ﹤0.01% 1230

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Quantamental Technologies's ACIU Position: Q4 2019 in Review

Quantamental Technologies sold out of AC Immune (ACIU) in Q4 2019, closing a stake of 1,743 shares — an estimated $9K sold.

Quantamental Technologies first reported a position in ACIU in Q2 2019 and held it in 2 quarters. The position peaked at $11K in Q2 2019. 48 funds tracked by Wall St. Rank hold ACIU as of Q4 2019.

  • Quantamental Technologies reported no remaining AC Immune position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 1,743 AC Immune shares in Q4 2019, an estimated $9K.
  • Quantamental Technologies first reported a position in AC Immune in Q2 2019 and held it in 2 quarters.
  • Quantamental Technologies's AC Immune position peaked at $11K in Q2 2019.
  • 48 funds tracked by Wall St. Rank held AC Immune as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.